Search

Search Constraints

You searched for: Date 2022 Author/Creator Sachdev, Sean

Search Results

1. Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas. Issue 3 (17th August 2022)

2. EXTH-88. DOCETAXEL TARGETS AGGRESSIVE METHYLATION PROFILES AND SERVES AS A RADIOSENSITIZER IN HIGH-RISK MENINGIOMAS. (14th November 2022)

3. Hippocampus sparing volumetric modulated arc therapy in patients with loco-regionally advanced oropharyngeal cancer. (October 2022)